Missing data in trials: Do we have to keep carrying the last observation forward?


  • Maarten Boers

    Corresponding author
    1. VU University Medical Center, Amsterdam, The Netherlands
    • PO Box 7057, Amsterdam, The Netherlands 1007 MB
    Search for more papers by this author
    • Dr. Boers received consultant fees (less than $10,000 each) from Sanofi, Bristol-Meyers Squibb, Genentech, Novartis, GlaxoSmithKline, Nitec, and Atlas Ventures.

No abstract is available for this article.